A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.

ImmunityBio’s IBRX QUILT-2.005 trial tops enrollment forecasts; BLA filing targeted by year-end after positive ANKTIVA+BCG ...

People with color vision deficiency -- commonly known as color blindness -- may have a higher risk of mortality from bladder ...

ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best penny stocks to buy for 2026. On December 16, ImmunityBio, Inc.

A mum-of-two from Kirkby Lonsdale has become the first patient in the region to receive innovative treatment for bladder ...

Discover a comprehensive palliative care plan designed to enhance quality of life for those with metastatic bladder cancer.

The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year.

A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...

Bladder cancer imaging and diagnosis have evolved significantly with the integration of advanced magnetic resonance imaging (MRI) techniques and artificial intelligence (AI)-driven analytical methods.

The collaborative clinical study will evaluate ADSTILADRIN® (nadofaragene firadenovec-vncg) in combination with the ...

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...

Dr. Soon-Shiong is hopeful the Saudi Arabian FDA's approval of his cancer therapy drug, Anktiva, will lead to widespread ...